Results 11 to 20 of about 551,653 (258)

Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis

open access: yesBioengineering & Translational Medicine, 2022
Alzheimer's disease (AD) is an aging‐related neurodegenerative disease. The main pathological features of AD are β‐amyloid protein (Aβ) deposition and tau protein hyperphosphorylation. Currently, there are no effective drugs for the etiological treatment
Ruiyi Zhou   +8 more
doaj   +1 more source

Targeting Dystroglycan in the Brain [PDF]

open access: yesNeuron, 2003
The dystrophin-glycoprotein complex is a multisubunit complex that connects the extracellular matrix components to the cytoskeletal matrix of muscle fiber cells and is required for muscle integrity. Mutations in this complex are associated with muscular dystrophy.
Montanaro, F., Carbonetto, S.
openaire   +2 more sources

Nanogels as novel drug nanocarriers for CNS drug delivery

open access: yesFrontiers in Molecular Biosciences, 2023
Nanogels are highly recognized as adaptable drug delivery systems that significantly contribute to improving various therapies and diagnostic examinations for different human diseases.
V. Manimaran   +14 more
doaj   +1 more source

Small extracellular vesicles: a novel drug delivery system for neurodegenerative disorders

open access: yesFrontiers in Aging Neuroscience, 2023
Neurodegenerative diseases (NDs) have a slow onset and are usually detected late during disease. NDs are often difficult to cure due to the presence of the blood–brain barrier (BBB), which makes it difficult to find effective treatments and drugs ...
Renjie Pan   +9 more
doaj   +1 more source

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies

open access: yesPharmaceutics, 2023
Numerous neurological disorders have a pathophysiology that involves an increase in free radical production in the brain. Quercetin (QER) is a nutraceutical compound that shields the brain against oxidative stress-induced neurodegeneration.
Mohammed H. Elkomy   +10 more
doaj   +1 more source

Brain-based target expansion [PDF]

open access: yesProceedings of the 27th annual ACM symposium on User interface software and technology, 2014
The bubble cursor is a promising cursor expansion technique, improving a user's movement time and accuracy in pointing tasks. We introduce a brain-based target expansion system, which improves the efficacy of bubble cursor by increasing the expansion of high importance targets at the optimal time based on brain measurements correlated to a particular ...
Daniel Afergan   +6 more
openaire   +1 more source

Development and Evaluation of Nanosuspension Loaded Nanogel of Nortriptyline HCl for Brain Delivery

open access: yesEngineering Proceedings, 2023
Nanogel systems loaded with nanosuspension area promising approach tonose-to-brain delivery in order to reduce the dose and dosing frequency and also improve the bioavailability of the drug.
Akash J. Amkar   +2 more
doaj   +1 more source

Brain-Targeted Intranasal Delivery of Zotepine Microemulsion: Pharmacokinetics and Pharmacodynamics

open access: yesPharmaceutics, 2022
The purpose of our study was to improve the solubility, bioavailability, and efficacy of zotepine (ZTP) by brain-targeted intranasal delivery of microemulsion (ME) and its physicochemical properties, the pharmacokinetic and pharmacodynamic parameters ...
Sravanthi Reddy Pailla   +5 more
doaj   +1 more source

Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route

open access: yesPharmaceuticals, 2022
This research aimed to design, optimize, and evaluate berberine-laden nanostructured lipid carriers overlaid with chitosan (BER-CTS-NLCs) for efficient brain delivery via the intranasal route.
Hadel A. Abo El-Enin   +7 more
doaj   +1 more source

Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting

open access: yesGels, 2023
Dolutegravir’s therapeutic effectiveness in the management of neuroAIDS is mainly limited by its failure to cross the blood–brain barrier. However, lipid-based nanovesicles such as nanoemulsions have demonstrated their potential for the brain targeting ...
Anroop B. Nair   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy